Anixa Biosciences Inc

NAS:ANIXHealthcarenasdaq_composite

$2.73+4.60%LiveIn session · ≈ AED 10.03 · Market cap $94.91M · Next earnings Wed 6 Jan

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	24.8%	—	23.3%	—	—	—	—
Operating margin	—	−2,565.6%	—	−5,243.3%	—	—	—	—
Net margin	—	−2,528.6%	—	−4,671.9%	—	—	—	—
EBITDA margin	—	−2,554.9%	—	−4,706.7%	—	—	—	—
Return on equity	−115.7%	−36.5%	−46.8%	−40.3%	−62.8%	−72.1%	−78.3%	−6.3 pts
Return on assets	−107.2%	−35.7%	−44.7%	−38.4%	−58.1%	−68.0%	−68.0%	+0.0 pts
Return on capital employed	−120.7%	−37.5%	−48.9%	−46.9%	−72.4%	−82.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+8.7%
Debt / assets	0.6%	0.7%	0.7%	0.7%	1.1%	1.3%	—	—
Interest coverage	0.0×	−40,794.1×	−133.4×	0.0×	0.0×	0.0×	—	—
Current ratio	7.9×	28.3×	14.8×	12.5×	8.5×	8.1×	8.1×	+0.0%
Quick ratio	7.9×	28.3×	14.8×	12.5×	8.5×	8.1×	—	—
Cash ratio	5.4×	22.9×	6.1×	0.5×	0.5×	0.6×	0.6×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	—	—	0.0×	—	—	—	—	—
Receivables turnover	0.0×	—	0.0×	0.8×	0.0×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Oct 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.